Using open-label placebos to reduce acute pain in healthy adults
Official title: Boosting Open-Label Placebo Effects in Acute Induced Pain in Healthy Adults
Run by University Hospital, Basel, Switzerland · NCT05819476 · Data updated 2026-11-12
This study tests whether open-label placebos can help healthy adults feel less pain from simulated wounds caused by electrical stimulation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 141 (estimated) |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 1 site (Basel) |
| Status | Recruiting |
| Started | March 23, 2023 |
| Main results expected | June 2025 |
| Study ends | June 2025 |
| Registry record updated | January 24, 2025 |
| Trial ID | NCT05819476 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults aged 18 to 65 with a BMI between 18 and 25 who can understand the study and provide informed consent.
✕Probably not a fit
Patients with chronic pain, neuropathy, or those taking medications that interfere with pain sensation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of open-label placebo (OLP) on acute pain using an experimental model that simulates wound pain through electrical stimulation. Participants will undergo a randomized crossover design where they will receive OLP injections and their pain responses will be measured. The study aims to evaluate the duration and efficacy of OLP analgesia, comparing different administration methods. The research seeks to explore the potential of OLP as a non-deceptive treatment option for managing acute pain.
Why it matters
Potential benefit: If successful, this approach could provide a novel, non-pharmacological method for managing acute pain without the side effects associated with traditional analgesics.
How similar studies have gone: While the use of open-label placebos is a relatively novel approach, previous studies have shown promising results in various conditions, indicating potential for success in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy volunteers (ASA Class I or II), aged 18 to 65 years * BMI between 18 and 25kg/m2 * Able to understand the study and the NRS * Able to give informed consent Exclusion Criteria: * Participation in a previous open-label placebo study; for Part 2, this includes Part 1 of this study * Regular intake of medications or drugs potentially interfering with pain sensation (analgesics, opioids, antihistamines, calcium and potassium channel blockers, serotonin/ noradrenaline reuptake inhibitors, corticosteroids) * Neuropathy * Chronic pain * Neuromuscular disease * Dermatological disease (i.e. Atopic Dermatitis) * Psychiatric disease * Pregnancy / Lactation
Where it's running
-
University Hospital of Basel (USB); Department of Anaesthesiology
Basel, Switzerland Recruiting
Study contacts
- Principal investigator: Tobias Schneider, MD — Department of Anaesthesiology, University Hospital of Basel (USB)
- Study coordinator: Tobias Schneider, MD
- Email: tobias.schneider@usb.ch
- Phone: +41 61 328 65 43
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predictors of severe pain within 24 hours after cesarean delivery with spinal anesthesia
This study will look at which pre-, intra-, and post-operative factors are linked to severe pain in the first 24 hours after an elective cesarean done with spinal anesthesia.
-
Transverse vs Longitudinal Serratus Anterior Plane Block for Breast Surgery
This trial tests whether a longitudinal ultrasound view for serratus anterior plane block provides better pain relief after breast surgery than the standard transverse view.
-
Combined PECS II and PIP blocks vs TPVB for post-mastectomy pain relief
This trial tests whether a combination of PECS II and superficial PIP blocks can provide better or similar pain relief after mastectomy compared with the standard thoracic paravertebral block.
-
Ketamine or Dexmedetomidine as an Additive to Scalp Block for Brain Tumor Surgery
This trial tests whether adding ketamine or dexmedetomidine to bupivacaine for scalp blocks improves pain control after supratentorial brain tumor removal.
-
Rhythmic Skin Tapping and Internal Vibration for Pediatric Venipuncture Pain and Fear
This study tests whether light fingertip tapping above the needle site or a humming sound can reduce pain and fear in children aged 6-12 during blood draws.
-
Brief audio-guided mindfulness for pain in orthopedic waiting rooms
This trial tests whether listening to short mindfulness audio clips can help reduce pain for adults waiting for orthopedic care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.